ReviewGlobal mental health (Cambridge, England)2026
The regulation and control of khat use and access in Ethiopia: Policy brief.
Review in Global mental health (Cambridge, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
About 10 million people worldwide chew khat daily. Chronic khat use is a public health problem associated with physical and psychological impacts, such as mental health disorders and social consequences. The use of khat is increasing dramatically in Ethiopia among the young population. There are controversies over the legal status and health effects related to the consumption of khat. Despite the existing controversies, the problem is increasing with its detrimental impact. Policymakers need to enforce education campaigns aimed at awareness creation on the impact of khat use. It is important to consider legally restricting the availability and use of khat in vulnerable populations, such as children under 18 years, individuals with mental disorders and pregnant women, as well as in settings such as hospitals and schools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.